Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Chemical Biology|May 12, 2010
Acylating drugs: redesigning natural covalent inhibitorsArthur F Kluge, Russell C Petter
Current Opinion in Chemical Biology|July 9, 2010
Targeted covalent drugs of the kinase familyJuswinder Singh, Russell C Petter, Arthur F Kluge
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Antifungal activity of a Candida albicans GGTase I inhibitor-alanine conjugate. Inhibition of Rho1p prenylation in C. albicansKrishna K Murthi, Susan E Smith, Arthur F Kluge, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 2020
Addressing hERG activity while maintaining favorable potency, selectivity and pharmacokinetic properties of PPARδ modulatorsBharat Lagu, Ramesh S Senaiar, Arthur F Kluge, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2018
Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagyArthur F Kluge, Bharat R Lagu, Pranab Maiti, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2017
Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosingBharat Lagu, Arthur F Kluge, Ross A Fredenburg, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2017
Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516Bharat Lagu, Arthur F Kluge, Matthew M Goddeeris, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Correction to "Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)"Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.
Chemistry & Biology|May 5, 2004
A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitorsFrank Becker, Krishna Murthi, Chase Smith, et al.
Pageof 2